Doug Samuelson
Chief Financial Officer at Kairos Pharma, LTD. (KAPA)
Doug Samuelson has filed 6 insider reports with the SEC since May 2023, as chief Financial Officer at Kairos Pharma, LTD. (KAPA), chief Financial Officer at Sacks Parente Golf, Inc. (NWTG) and officer at GENELUX Corp (GNLX). Doug Samuelson made no open-market purchases or sales in the last 12 months. The latest filing, on November 26, 2025, reports grant or award at Kairos Pharma, LTD. (KAPA).
- Filings
- 6
- Companies
- 3
- Bought on market
- $3,750
- Sold on market
- $30.8K
Companies where Doug Samuelson is an insider
| Company | Role | Shares held | Bought | Sold | Last filing |
|---|---|---|---|---|---|
| KAPA Kairos Pharma, LTD. | Chief Financial Officer | 293,039 | $3,750 | Nov 26, 2025 | |
| NWTG Sacks Parente Golf, Inc. | Chief Financial Officer | Sep 12, 2024 | |||
| GNLX GENELUX Corp | Officer | 2,303 | $30.8K | Sep 12, 2023 |
Shares held: common shares owned directly after the latest filing that states it.
Every filing
- Oct 8, 2025KAPAChief Financial Officer Samuelson Doug was granted 152,672 shares, increasing direct ownership by 109% to 293,039 unitsForm 4Grant or award
- Nov 22, 2024+$3,750KAPAChief Financial Officer Samuelson Doug bought $3,750 worth of shares (2,500 units at $1.50), increasing direct ownership by 4% to 60,796 unitsForm 4/AOpen-market purchase
- Sep 9, 2024NWTGSEC Form 4 filed by Chief Financial Officer Samuelson DougForm 4Grant or award
- Sep 11, 2023GNLXSEC Form 4 filed by Samuelson DougForm 4Grant or award
- Aug 18, 2023-$30.8KGNLXSEC Form 4: Samuelson Doug sold $30,778 worth of shares (1,297 units at $23.73), decreasing direct ownership by 36% to 2,303 unitsForm 4Open-market sale
- Feb 17, 2023GNLXSEC Form 4 filed by Samuelson DougForm 4Grant or award
Other insiders at the same companies
- Thomas ZindrickGNLX
- Joseph CappelloGNLX
- Yong YuGNLX
- Brett Widney HogeNWTG
- John W SmitherGNLX
- Jane CasantaNWTG
- Akinobu YorihiroNWTG
- Jeff ClayborneNWTG
- James L TyreeGNLX
- John ThomasGNLX
- Matthew PulisicGNLX
- Eric GroenGNLX
- Mary MirabelliGNLX
- Ralph SmallingGNLX
- Gregg HemphillNWTG
- John B BodeNWTG
Questions about Doug Samuelson
- What is Doug Samuelson's role at Kairos Pharma, LTD.?
- Doug Samuelson reports to the SEC as chief Financial Officer at Kairos Pharma, LTD. (KAPA), according to the latest filing on November 26, 2025. Doug Samuelson has also filed as chief Financial Officer at Sacks Parente Golf, Inc. (NWTG) and officer at GENELUX Corp (GNLX).
- How many shares does Doug Samuelson own?
- After the latest filing that states it, Doug Samuelson directly owned 293,039 shares of Kairos Pharma, LTD. (KAPA) and 2,303 shares of GENELUX Corp (GNLX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Doug Samuelson bought or sold stock recently?
- The most recent open-market purchase was on November 22, 2024: bought 2,500 shares of Kairos Pharma, LTD. (KAPA) for $3,750 at an average of $1.50. The most recent open-market sale was on August 18, 2023: sold 1,297 shares of GENELUX Corp (GNLX) for $30.8K at an average of $23.73.
- How do I get alerts when Doug Samuelson files?
- Follow Doug Samuelson on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5.
From SEC Forms 4 and 5 filed by Doug Samuelson (SEC CIK 0001943326). Totals count each trade once, skipping amendments whose original is on file, from May 2, 2023 on. View on SEC EDGAR